Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 6Pain, Postoperative 5Brain Neoplasms 5Lung Neoplasms 3Delirium 3Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Kidney Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Thromboembolism 1Synovial Cyst 1Surgical Wound Infection 1Supratentorial Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1Scleroderma, Localized 1Radiculopathy 1Prostatic Neoplasms 1Postoperative Hemorrhage 1Pituitary Neoplasms 1Pituitary Diseases 1Otolaryngeal Cancer 1

Interventions

Saline Solution 2fosaprepitant 1fluciclovine F-18 1ferrous fumarate 1Lidocaine 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Uterine Neoplasms × Saline Solution × Clear all
NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Gynecologic Oncology Associates

Phase 4 Completed
20 enrolled 5 charts
Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

NCT01492179 2014-05-28

PoPuLAR

Örebro University, Sweden

Phase 4 Completed
60 enrolled
Gynecologic

Pain, Postoperative, Uterine Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡